nodes	percent_of_prediction	percent_of_DWPC	metapath
Dimenhydrinate—Chest discomfort—Metformin—polycystic ovary syndrome	0.0121	0.103	CcSEcCtD
Dimenhydrinate—Nasal congestion—Metformin—polycystic ovary syndrome	0.0085	0.0726	CcSEcCtD
Dimenhydrinate—Modafinil—ADRA1B—polycystic ovary syndrome	0.00819	1	CrCbGaD
Dimenhydrinate—Sweating increased—Metformin—polycystic ovary syndrome	0.00652	0.0557	CcSEcCtD
Dimenhydrinate—Drowsiness—Metformin—polycystic ovary syndrome	0.00597	0.051	CcSEcCtD
Dimenhydrinate—Neuropathy peripheral—Metformin—polycystic ovary syndrome	0.00585	0.05	CcSEcCtD
Dimenhydrinate—Chills—Metformin—polycystic ovary syndrome	0.00481	0.0411	CcSEcCtD
Dimenhydrinate—Vision blurred—Metformin—polycystic ovary syndrome	0.0044	0.0376	CcSEcCtD
Dimenhydrinate—Tremor—Metformin—polycystic ovary syndrome	0.00437	0.0373	CcSEcCtD
Dimenhydrinate—Palpitations—Metformin—polycystic ovary syndrome	0.00412	0.0352	CcSEcCtD
Dimenhydrinate—Thrombocytopenia—Metformin—polycystic ovary syndrome	0.00373	0.0318	CcSEcCtD
Dimenhydrinate—Hyperhidrosis—Metformin—polycystic ovary syndrome	0.00368	0.0314	CcSEcCtD
Dimenhydrinate—Anorexia—Metformin—polycystic ovary syndrome	0.00363	0.031	CcSEcCtD
Dimenhydrinate—Hypotension—Metformin—polycystic ovary syndrome	0.00356	0.0304	CcSEcCtD
Dimenhydrinate—Paraesthesia—Metformin—polycystic ovary syndrome	0.00342	0.0292	CcSEcCtD
Dimenhydrinate—Somnolence—Metformin—polycystic ovary syndrome	0.00338	0.0289	CcSEcCtD
Dimenhydrinate—Dyspepsia—Metformin—polycystic ovary syndrome	0.00335	0.0286	CcSEcCtD
Dimenhydrinate—Decreased appetite—Metformin—polycystic ovary syndrome	0.00331	0.0283	CcSEcCtD
Dimenhydrinate—Fatigue—Metformin—polycystic ovary syndrome	0.00328	0.028	CcSEcCtD
Dimenhydrinate—Constipation—Metformin—polycystic ovary syndrome	0.00326	0.0278	CcSEcCtD
Dimenhydrinate—HRH1—GPCR ligand binding—LHCGR—polycystic ovary syndrome	0.00324	0.00371	CbGpPWpGaD
Dimenhydrinate—HRH1—GPCRs, Class A Rhodopsin-like—ADRB3—polycystic ovary syndrome	0.0032	0.00366	CbGpPWpGaD
Dimenhydrinate—CHRM2—GPCR ligand binding—LHCGR—polycystic ovary syndrome	0.00319	0.00365	CbGpPWpGaD
Dimenhydrinate—CHRM2—GPCR ligand binding—PTGER3—polycystic ovary syndrome	0.00319	0.00365	CbGpPWpGaD
Dimenhydrinate—CHRM2—GPCRs, Class A Rhodopsin-like—ADRB3—polycystic ovary syndrome	0.00315	0.0036	CbGpPWpGaD
Dimenhydrinate—Feeling abnormal—Metformin—polycystic ovary syndrome	0.00314	0.0268	CcSEcCtD
Dimenhydrinate—HRH1—Class A/1 (Rhodopsin-like receptors)—FSHR—polycystic ovary syndrome	0.00312	0.00356	CbGpPWpGaD
Dimenhydrinate—CHRM2—Class A/1 (Rhodopsin-like receptors)—FSHR—polycystic ovary syndrome	0.00307	0.00351	CbGpPWpGaD
Dimenhydrinate—HRH1—GPCR ligand binding—PTAFR—polycystic ovary syndrome	0.00303	0.00347	CbGpPWpGaD
Dimenhydrinate—Urticaria—Metformin—polycystic ovary syndrome	0.00302	0.0258	CcSEcCtD
Dimenhydrinate—CHRM2—G alpha (i) signalling events—MTNR1B—polycystic ovary syndrome	0.003	0.00343	CbGpPWpGaD
Dimenhydrinate—CHRM2—GPCR ligand binding—PTAFR—polycystic ovary syndrome	0.00298	0.00341	CbGpPWpGaD
Dimenhydrinate—HRH1—GPCR ligand binding—ADRA1D—polycystic ovary syndrome	0.00294	0.00337	CbGpPWpGaD
Dimenhydrinate—CHRM2—GPCR ligand binding—ADRA1D—polycystic ovary syndrome	0.0029	0.00331	CbGpPWpGaD
Dimenhydrinate—CHRM2—SIDS Susceptibility Pathways—TH—polycystic ovary syndrome	0.00289	0.0033	CbGpPWpGaD
Dimenhydrinate—HRH1—GPCR ligand binding—ADRA1B—polycystic ovary syndrome	0.00286	0.00327	CbGpPWpGaD
Dimenhydrinate—HRH1—Class A/1 (Rhodopsin-like receptors)—ADRA1A—polycystic ovary syndrome	0.00285	0.00326	CbGpPWpGaD
Dimenhydrinate—HRH1—GPCRs, Class A Rhodopsin-like—MTNR1B—polycystic ovary syndrome	0.00283	0.00323	CbGpPWpGaD
Dimenhydrinate—CHRM2—GPCR ligand binding—ADRA1B—polycystic ovary syndrome	0.00282	0.00322	CbGpPWpGaD
Dimenhydrinate—CHRM2—Class A/1 (Rhodopsin-like receptors)—ADRA1A—polycystic ovary syndrome	0.0028	0.00321	CbGpPWpGaD
Dimenhydrinate—CHRM2—GPCRs, Class A Rhodopsin-like—MTNR1B—polycystic ovary syndrome	0.00278	0.00318	CbGpPWpGaD
Dimenhydrinate—HRH1—Class A/1 (Rhodopsin-like receptors)—ADRB3—polycystic ovary syndrome	0.00274	0.00314	CbGpPWpGaD
Dimenhydrinate—Asthenia—Metformin—polycystic ovary syndrome	0.00273	0.0233	CcSEcCtD
Dimenhydrinate—HRH1—Class A/1 (Rhodopsin-like receptors)—LHB—polycystic ovary syndrome	0.00271	0.0031	CbGpPWpGaD
Dimenhydrinate—HRH1—G alpha (q) signalling events—GHRL—polycystic ovary syndrome	0.0027	0.00309	CbGpPWpGaD
Dimenhydrinate—CHRM2—Class A/1 (Rhodopsin-like receptors)—ADRB3—polycystic ovary syndrome	0.0027	0.00309	CbGpPWpGaD
Dimenhydrinate—CHRM2—Class A/1 (Rhodopsin-like receptors)—LHB—polycystic ovary syndrome	0.00267	0.00305	CbGpPWpGaD
Dimenhydrinate—HRH1—Class A/1 (Rhodopsin-like receptors)—GNRH1—polycystic ovary syndrome	0.00265	0.00303	CbGpPWpGaD
Dimenhydrinate—CHRM2—Calcium Regulation in the Cardiac Cell—ADRB2—polycystic ovary syndrome	0.00264	0.00302	CbGpPWpGaD
Dimenhydrinate—CHRM2—Class A/1 (Rhodopsin-like receptors)—GNRH1—polycystic ovary syndrome	0.00261	0.00298	CbGpPWpGaD
Dimenhydrinate—Diarrhoea—Metformin—polycystic ovary syndrome	0.0026	0.0222	CcSEcCtD
Dimenhydrinate—CHRM2—SIDS Susceptibility Pathways—AR—polycystic ovary syndrome	0.00257	0.00294	CbGpPWpGaD
Dimenhydrinate—Dizziness—Metformin—polycystic ovary syndrome	0.00252	0.0215	CcSEcCtD
Dimenhydrinate—CHRM2—Calcium Regulation in the Cardiac Cell—GNAS—polycystic ovary syndrome	0.00245	0.0028	CbGpPWpGaD
Dimenhydrinate—HRH1—Class A/1 (Rhodopsin-like receptors)—MTNR1B—polycystic ovary syndrome	0.00242	0.00277	CbGpPWpGaD
Dimenhydrinate—Vomiting—Metformin—polycystic ovary syndrome	0.00242	0.0207	CcSEcCtD
Dimenhydrinate—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—GHRL—polycystic ovary syndrome	0.00242	0.00276	CbGpPWpGaD
Dimenhydrinate—Rash—Metformin—polycystic ovary syndrome	0.0024	0.0205	CcSEcCtD
Dimenhydrinate—Dermatitis—Metformin—polycystic ovary syndrome	0.0024	0.0205	CcSEcCtD
Dimenhydrinate—CHRM2—Class A/1 (Rhodopsin-like receptors)—MTNR1B—polycystic ovary syndrome	0.00238	0.00273	CbGpPWpGaD
Dimenhydrinate—Headache—Metformin—polycystic ovary syndrome	0.00238	0.0204	CcSEcCtD
Dimenhydrinate—HRH1—GPCR ligand binding—FSHR—polycystic ovary syndrome	0.00237	0.00271	CbGpPWpGaD
Dimenhydrinate—CHRM2—GPCR ligand binding—FSHR—polycystic ovary syndrome	0.00234	0.00267	CbGpPWpGaD
Dimenhydrinate—Nausea—Metformin—polycystic ovary syndrome	0.00226	0.0193	CcSEcCtD
Dimenhydrinate—HRH1—GPCR downstream signaling—NPB—polycystic ovary syndrome	0.0022	0.00251	CbGpPWpGaD
Dimenhydrinate—HRH1—GPCR ligand binding—ADRA1A—polycystic ovary syndrome	0.00217	0.00248	CbGpPWpGaD
Dimenhydrinate—CHRM2—GPCR downstream signaling—NPB—polycystic ovary syndrome	0.00216	0.00247	CbGpPWpGaD
Dimenhydrinate—CHRM2—GPCR ligand binding—ADRA1A—polycystic ovary syndrome	0.00214	0.00244	CbGpPWpGaD
Dimenhydrinate—HRH1—GPCR ligand binding—ADRB3—polycystic ovary syndrome	0.00209	0.00239	CbGpPWpGaD
Dimenhydrinate—CHRM2—SIDS Susceptibility Pathways—NR3C1—polycystic ovary syndrome	0.00208	0.00238	CbGpPWpGaD
Dimenhydrinate—HRH1—GPCR ligand binding—LHB—polycystic ovary syndrome	0.00206	0.00236	CbGpPWpGaD
Dimenhydrinate—CHRM2—GPCR ligand binding—ADRB3—polycystic ovary syndrome	0.00206	0.00235	CbGpPWpGaD
Dimenhydrinate—CHRM2—GPCR ligand binding—LHB—polycystic ovary syndrome	0.00203	0.00232	CbGpPWpGaD
Dimenhydrinate—HRH1—GPCR ligand binding—GNRH1—polycystic ovary syndrome	0.00202	0.00231	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling by GPCR—NPB—polycystic ovary syndrome	0.00199	0.00228	CbGpPWpGaD
Dimenhydrinate—CHRM2—GPCR ligand binding—GNRH1—polycystic ovary syndrome	0.00199	0.00227	CbGpPWpGaD
Dimenhydrinate—HRH1—GPCR downstream signaling—PLEKHG5—polycystic ovary syndrome	0.00199	0.00227	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling by GPCR—NPB—polycystic ovary syndrome	0.00196	0.00224	CbGpPWpGaD
Dimenhydrinate—CHRM2—GPCR downstream signaling—PLEKHG5—polycystic ovary syndrome	0.00195	0.00223	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—ARHGAP23—polycystic ovary syndrome	0.00194	0.00222	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—ARHGAP30—polycystic ovary syndrome	0.00194	0.00222	CbGpPWpGaD
Dimenhydrinate—HRH1—GPCR ligand binding—SCT—polycystic ovary syndrome	0.00193	0.00221	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—ARHGAP30—polycystic ovary syndrome	0.00191	0.00219	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—ARHGAP23—polycystic ovary syndrome	0.00191	0.00219	CbGpPWpGaD
Dimenhydrinate—CHRM2—GPCR ligand binding—SCT—polycystic ovary syndrome	0.0019	0.00218	CbGpPWpGaD
Dimenhydrinate—HRH1—GPCR ligand binding—MTNR1B—polycystic ovary syndrome	0.00185	0.00211	CbGpPWpGaD
Dimenhydrinate—HRH1—GPCR downstream signaling—PTGER3—polycystic ovary syndrome	0.00183	0.00209	CbGpPWpGaD
Dimenhydrinate—HRH1—GPCR downstream signaling—LHCGR—polycystic ovary syndrome	0.00183	0.00209	CbGpPWpGaD
Dimenhydrinate—CHRM2—GPCR ligand binding—MTNR1B—polycystic ovary syndrome	0.00182	0.00208	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling by GPCR—PLEKHG5—polycystic ovary syndrome	0.0018	0.00206	CbGpPWpGaD
Dimenhydrinate—CHRM2—GPCR downstream signaling—PTGER3—polycystic ovary syndrome	0.0018	0.00206	CbGpPWpGaD
Dimenhydrinate—CHRM2—GPCR downstream signaling—LHCGR—polycystic ovary syndrome	0.0018	0.00206	CbGpPWpGaD
Dimenhydrinate—HRH1—Class A/1 (Rhodopsin-like receptors)—GHRL—polycystic ovary syndrome	0.00179	0.00205	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling by GPCR—PLEKHG5—polycystic ovary syndrome	0.00177	0.00203	CbGpPWpGaD
Dimenhydrinate—CHRM2—Class A/1 (Rhodopsin-like receptors)—GHRL—polycystic ovary syndrome	0.00176	0.00201	CbGpPWpGaD
Dimenhydrinate—HRH1—GPCRs, Class A Rhodopsin-like—ADRB2—polycystic ovary syndrome	0.00173	0.00198	CbGpPWpGaD
Dimenhydrinate—HRH1—GPCR downstream signaling—PTAFR—polycystic ovary syndrome	0.00171	0.00196	CbGpPWpGaD
Dimenhydrinate—CHRM2—GPCRs, Class A Rhodopsin-like—ADRB2—polycystic ovary syndrome	0.0017	0.00195	CbGpPWpGaD
Dimenhydrinate—CHRM2—G alpha (i) signalling events—GNAS—polycystic ovary syndrome	0.0017	0.00194	CbGpPWpGaD
Dimenhydrinate—CHRM2—GPCR downstream signaling—PTAFR—polycystic ovary syndrome	0.00169	0.00193	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling by GPCR—LHCGR—polycystic ovary syndrome	0.00166	0.0019	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling by GPCR—PTGER3—polycystic ovary syndrome	0.00166	0.0019	CbGpPWpGaD
Dimenhydrinate—HRH1—GPCR downstream signaling—ADRA1D—polycystic ovary syndrome	0.00166	0.0019	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling by GPCR—PTGER3—polycystic ovary syndrome	0.00164	0.00187	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling by GPCR—LHCGR—polycystic ovary syndrome	0.00164	0.00187	CbGpPWpGaD
Dimenhydrinate—CHRM2—GPCR downstream signaling—ADRA1D—polycystic ovary syndrome	0.00164	0.00187	CbGpPWpGaD
Dimenhydrinate—HRH1—GPCR downstream signaling—ADRA1B—polycystic ovary syndrome	0.00162	0.00185	CbGpPWpGaD
Dimenhydrinate—CHRM2—GPCR downstream signaling—ADRA1B—polycystic ovary syndrome	0.00159	0.00182	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling by GPCR—PTAFR—polycystic ovary syndrome	0.00156	0.00178	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling by GPCR—PTAFR—polycystic ovary syndrome	0.00153	0.00175	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling by GPCR—ADRA1D—polycystic ovary syndrome	0.00151	0.00173	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling by GPCR—ADRA1D—polycystic ovary syndrome	0.00149	0.0017	CbGpPWpGaD
Dimenhydrinate—HRH1—Class A/1 (Rhodopsin-like receptors)—ADRB2—polycystic ovary syndrome	0.00148	0.00169	CbGpPWpGaD
Dimenhydrinate—HRH1—GPCR downstream signaling—PDE3B—polycystic ovary syndrome	0.00147	0.00168	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling by GPCR—ADRA1B—polycystic ovary syndrome	0.00147	0.00168	CbGpPWpGaD
Dimenhydrinate—CHRM2—Class A/1 (Rhodopsin-like receptors)—ADRB2—polycystic ovary syndrome	0.00146	0.00167	CbGpPWpGaD
Dimenhydrinate—CHRM2—GPCR downstream signaling—PDE3B—polycystic ovary syndrome	0.00145	0.00166	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling by GPCR—ADRA1B—polycystic ovary syndrome	0.00145	0.00165	CbGpPWpGaD
Dimenhydrinate—HRH1—GPCR ligand binding—GHRL—polycystic ovary syndrome	0.00136	0.00156	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—FLT4—polycystic ovary syndrome	0.00135	0.00154	CbGpPWpGaD
Dimenhydrinate—CHRM2—GPCR ligand binding—GHRL—polycystic ovary syndrome	0.00134	0.00153	CbGpPWpGaD
Dimenhydrinate—HRH1—GPCR downstream signaling—FSHR—polycystic ovary syndrome	0.00134	0.00153	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling by GPCR—PDE3B—polycystic ovary syndrome	0.00134	0.00153	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—FLT4—polycystic ovary syndrome	0.00133	0.00152	CbGpPWpGaD
Dimenhydrinate—CHRM2—GPCR downstream signaling—FSHR—polycystic ovary syndrome	0.00132	0.00151	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling by GPCR—PDE3B—polycystic ovary syndrome	0.00132	0.0015	CbGpPWpGaD
Dimenhydrinate—HRH1—GPCR downstream signaling—ADRA1A—polycystic ovary syndrome	0.00123	0.0014	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling by GPCR—FSHR—polycystic ovary syndrome	0.00122	0.00139	CbGpPWpGaD
Dimenhydrinate—CHRM2—GPCR downstream signaling—ADRA1A—polycystic ovary syndrome	0.00121	0.00138	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling by GPCR—FSHR—polycystic ovary syndrome	0.0012	0.00137	CbGpPWpGaD
Dimenhydrinate—HRH1—GPCR downstream signaling—ADRB3—polycystic ovary syndrome	0.00118	0.00135	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—NPB—polycystic ovary syndrome	0.00118	0.00135	CbGpPWpGaD
Dimenhydrinate—HRH1—GPCR downstream signaling—LHB—polycystic ovary syndrome	0.00117	0.00133	CbGpPWpGaD
Dimenhydrinate—CHRM2—GPCR downstream signaling—ADRB3—polycystic ovary syndrome	0.00116	0.00133	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—NPB—polycystic ovary syndrome	0.00116	0.00132	CbGpPWpGaD
Dimenhydrinate—CHRM2—GPCR downstream signaling—LHB—polycystic ovary syndrome	0.00115	0.00131	CbGpPWpGaD
Dimenhydrinate—CHRM2—G alpha (i) signalling events—POMC—polycystic ovary syndrome	0.00114	0.00131	CbGpPWpGaD
Dimenhydrinate—HRH1—GPCR downstream signaling—GNRH1—polycystic ovary syndrome	0.00114	0.0013	CbGpPWpGaD
Dimenhydrinate—HRH1—GPCR ligand binding—ADRB2—polycystic ovary syndrome	0.00113	0.00129	CbGpPWpGaD
Dimenhydrinate—CHRM2—GPCR downstream signaling—GNRH1—polycystic ovary syndrome	0.00112	0.00128	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling by GPCR—ADRA1A—polycystic ovary syndrome	0.00111	0.00127	CbGpPWpGaD
Dimenhydrinate—CHRM2—GPCR ligand binding—ADRB2—polycystic ovary syndrome	0.00111	0.00127	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling by GPCR—ADRA1A—polycystic ovary syndrome	0.0011	0.00125	CbGpPWpGaD
Dimenhydrinate—HRH1—GPCR downstream signaling—SCT—polycystic ovary syndrome	0.00109	0.00125	CbGpPWpGaD
Dimenhydrinate—CHRM2—GPCR downstream signaling—SCT—polycystic ovary syndrome	0.00108	0.00123	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling by GPCR—ADRB3—polycystic ovary syndrome	0.00107	0.00123	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—PLEKHG5—polycystic ovary syndrome	0.00107	0.00122	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling by GPCR—LHB—polycystic ovary syndrome	0.00106	0.00121	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling by GPCR—ADRB3—polycystic ovary syndrome	0.00106	0.00121	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—PLEKHG5—polycystic ovary syndrome	0.00105	0.0012	CbGpPWpGaD
Dimenhydrinate—HRH1—GPCR ligand binding—GNAS—polycystic ovary syndrome	0.00105	0.0012	CbGpPWpGaD
Dimenhydrinate—HRH1—GPCR downstream signaling—MTNR1B—polycystic ovary syndrome	0.00104	0.00119	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling by GPCR—LHB—polycystic ovary syndrome	0.00104	0.00119	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling by GPCR—GNRH1—polycystic ovary syndrome	0.00104	0.00118	CbGpPWpGaD
Dimenhydrinate—CHRM2—GPCR ligand binding—GNAS—polycystic ovary syndrome	0.00103	0.00118	CbGpPWpGaD
Dimenhydrinate—CHRM2—GPCR downstream signaling—MTNR1B—polycystic ovary syndrome	0.00103	0.00117	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling by GPCR—GNRH1—polycystic ovary syndrome	0.00102	0.00116	CbGpPWpGaD
Dimenhydrinate—CHRM2—SIDS Susceptibility Pathways—VEGFA—polycystic ovary syndrome	0.000998	0.00114	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling by GPCR—SCT—polycystic ovary syndrome	0.000993	0.00114	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—PTGER3—polycystic ovary syndrome	0.000983	0.00112	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—LHCGR—polycystic ovary syndrome	0.000983	0.00112	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling by GPCR—SCT—polycystic ovary syndrome	0.000977	0.00112	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—PTGER3—polycystic ovary syndrome	0.000967	0.00111	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—LHCGR—polycystic ovary syndrome	0.000967	0.00111	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling by GPCR—MTNR1B—polycystic ovary syndrome	0.000947	0.00108	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling by GPCR—MTNR1B—polycystic ovary syndrome	0.000932	0.00107	CbGpPWpGaD
Dimenhydrinate—HRH1—Class A/1 (Rhodopsin-like receptors)—POMC—polycystic ovary syndrome	0.000925	0.00106	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—PTAFR—polycystic ovary syndrome	0.000919	0.00105	CbGpPWpGaD
Dimenhydrinate—CHRM2—Class A/1 (Rhodopsin-like receptors)—POMC—polycystic ovary syndrome	0.00091	0.00104	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—PTAFR—polycystic ovary syndrome	0.000905	0.00103	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—ADRA1D—polycystic ovary syndrome	0.000893	0.00102	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—ADRA1D—polycystic ovary syndrome	0.000878	0.001	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—ADRA1B—polycystic ovary syndrome	0.000868	0.000993	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—ADRA1B—polycystic ovary syndrome	0.000854	0.000977	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—INHBB—polycystic ovary syndrome	0.000846	0.000967	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—INHBB—polycystic ovary syndrome	0.000833	0.000952	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—PDE3B—polycystic ovary syndrome	0.00079	0.000903	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—PDE3B—polycystic ovary syndrome	0.000777	0.000889	CbGpPWpGaD
Dimenhydrinate—HRH1—GPCR downstream signaling—GHRL—polycystic ovary syndrome	0.00077	0.000881	CbGpPWpGaD
Dimenhydrinate—CHRM2—GPCR downstream signaling—GHRL—polycystic ovary syndrome	0.000758	0.000867	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—FSHR—polycystic ovary syndrome	0.00072	0.000823	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—FSHR—polycystic ovary syndrome	0.000708	0.000809	CbGpPWpGaD
Dimenhydrinate—HRH1—GPCR ligand binding—POMC—polycystic ovary syndrome	0.000704	0.000805	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling by GPCR—GHRL—polycystic ovary syndrome	0.0007	0.0008	CbGpPWpGaD
Dimenhydrinate—CHRM2—GPCR ligand binding—POMC—polycystic ovary syndrome	0.000693	0.000792	CbGpPWpGaD
Dimenhydrinate—CHRM2—SIDS Susceptibility Pathways—IL6—polycystic ovary syndrome	0.00069	0.000789	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling by GPCR—GHRL—polycystic ovary syndrome	0.000688	0.000787	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—RACGAP1—polycystic ovary syndrome	0.000676	0.000773	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—RACGAP1—polycystic ovary syndrome	0.000666	0.000761	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—ADRA1A—polycystic ovary syndrome	0.000658	0.000752	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—ADRA1A—polycystic ovary syndrome	0.000648	0.00074	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—FST—polycystic ovary syndrome	0.000641	0.000733	CbGpPWpGaD
Dimenhydrinate—HRH1—GPCR downstream signaling—ADRB2—polycystic ovary syndrome	0.000638	0.000729	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—ADRB3—polycystic ovary syndrome	0.000633	0.000724	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—FST—polycystic ovary syndrome	0.000631	0.000721	CbGpPWpGaD
Dimenhydrinate—CHRM2—GPCR downstream signaling—ADRB2—polycystic ovary syndrome	0.000627	0.000717	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—LHB—polycystic ovary syndrome	0.000626	0.000716	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—ADRB3—polycystic ovary syndrome	0.000623	0.000713	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—LHB—polycystic ovary syndrome	0.000616	0.000704	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—GNRH1—polycystic ovary syndrome	0.000612	0.000699	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—GNRH1—polycystic ovary syndrome	0.000602	0.000688	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—AKR1C1—polycystic ovary syndrome	0.000593	0.000677	CbGpPWpGaD
Dimenhydrinate—HRH1—GPCR downstream signaling—GNAS—polycystic ovary syndrome	0.000591	0.000676	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—SCT—polycystic ovary syndrome	0.000587	0.000671	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—AKR1C1—polycystic ovary syndrome	0.000583	0.000666	CbGpPWpGaD
Dimenhydrinate—CHRM2—GPCR downstream signaling—GNAS—polycystic ovary syndrome	0.000582	0.000665	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling by GPCR—ADRB2—polycystic ovary syndrome	0.000579	0.000662	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—SCT—polycystic ovary syndrome	0.000577	0.00066	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling by GPCR—ADRB2—polycystic ovary syndrome	0.00057	0.000651	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—MTNR1B—polycystic ovary syndrome	0.00056	0.00064	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—MTNR1B—polycystic ovary syndrome	0.000551	0.000629	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—FGF18—polycystic ovary syndrome	0.00055	0.000629	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—RBP4—polycystic ovary syndrome	0.000545	0.000623	CbGpPWpGaD
Dimenhydrinate—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—polycystic ovary syndrome	0.000543	0.000621	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—FGF18—polycystic ovary syndrome	0.000541	0.000619	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling by GPCR—GNAS—polycystic ovary syndrome	0.000537	0.000614	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—RBP4—polycystic ovary syndrome	0.000537	0.000613	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling by GPCR—GNAS—polycystic ovary syndrome	0.000528	0.000604	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—YAP1—polycystic ovary syndrome	0.000509	0.000582	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—GAB1—polycystic ovary syndrome	0.000502	0.000574	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—YAP1—polycystic ovary syndrome	0.000501	0.000573	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—GAB1—polycystic ovary syndrome	0.000494	0.000565	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—INSR—polycystic ovary syndrome	0.00048	0.000549	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—INSR—polycystic ovary syndrome	0.000472	0.00054	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—AKR1C3—polycystic ovary syndrome	0.000456	0.000521	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—TNRC6B—polycystic ovary syndrome	0.000449	0.000513	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—AKR1C3—polycystic ovary syndrome	0.000449	0.000513	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—PGR—polycystic ovary syndrome	0.000445	0.000508	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—TNRC6B—polycystic ovary syndrome	0.000442	0.000505	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—PGR—polycystic ovary syndrome	0.000437	0.0005	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—GHRL—polycystic ovary syndrome	0.000413	0.000472	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—PLAT—polycystic ovary syndrome	0.000413	0.000472	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—PLAT—polycystic ovary syndrome	0.000407	0.000465	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—GHRL—polycystic ovary syndrome	0.000407	0.000465	CbGpPWpGaD
Dimenhydrinate—HRH1—GPCR downstream signaling—POMC—polycystic ovary syndrome	0.000398	0.000455	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—ATF1—polycystic ovary syndrome	0.000394	0.000451	CbGpPWpGaD
Dimenhydrinate—CHRM2—GPCR downstream signaling—POMC—polycystic ovary syndrome	0.000392	0.000448	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—ATF1—polycystic ovary syndrome	0.000388	0.000443	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—TCF7L2—polycystic ovary syndrome	0.000384	0.000439	CbGpPWpGaD
Dimenhydrinate—HRH1—GPCR downstream signaling—AKT2—polycystic ovary syndrome	0.000383	0.000437	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—TCF7L2—polycystic ovary syndrome	0.000378	0.000432	CbGpPWpGaD
Dimenhydrinate—CHRM2—GPCR downstream signaling—AKT2—polycystic ovary syndrome	0.000377	0.00043	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—NGFR—polycystic ovary syndrome	0.000364	0.000416	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling by GPCR—POMC—polycystic ovary syndrome	0.000362	0.000413	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—PRL—polycystic ovary syndrome	0.000361	0.000412	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—NGFR—polycystic ovary syndrome	0.000358	0.000409	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling by GPCR—POMC—polycystic ovary syndrome	0.000356	0.000407	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—PRL—polycystic ovary syndrome	0.000355	0.000406	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling by GPCR—AKT2—polycystic ovary syndrome	0.000347	0.000397	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—ADRB2—polycystic ovary syndrome	0.000342	0.000391	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling by GPCR—AKT2—polycystic ovary syndrome	0.000342	0.000391	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—ADRB2—polycystic ovary syndrome	0.000337	0.000385	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—GNAS—polycystic ovary syndrome	0.000317	0.000363	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—GNAS—polycystic ovary syndrome	0.000312	0.000357	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—NCOR1—polycystic ovary syndrome	0.000302	0.000345	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—NCOR1—polycystic ovary syndrome	0.000297	0.00034	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—NRG1—polycystic ovary syndrome	0.000297	0.000339	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—NRG1—polycystic ovary syndrome	0.000292	0.000334	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—IRS2—polycystic ovary syndrome	0.000254	0.00029	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—IRS2—polycystic ovary syndrome	0.00025	0.000286	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—LEP—polycystic ovary syndrome	0.000249	0.000284	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—LEP—polycystic ovary syndrome	0.000245	0.00028	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—IRS1—polycystic ovary syndrome	0.000222	0.000254	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—IRS1—polycystic ovary syndrome	0.000218	0.000249	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—POMC—polycystic ovary syndrome	0.000214	0.000244	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—INS—polycystic ovary syndrome	0.000212	0.000243	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—POMC—polycystic ovary syndrome	0.00021	0.00024	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—INS—polycystic ovary syndrome	0.000209	0.000239	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—IGF1—polycystic ovary syndrome	0.000205	0.000235	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—AKT2—polycystic ovary syndrome	0.000205	0.000235	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—IGF1—polycystic ovary syndrome	0.000202	0.000231	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—AKT2—polycystic ovary syndrome	0.000202	0.000231	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—SERPINE1—polycystic ovary syndrome	0.000195	0.000223	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—SERPINE1—polycystic ovary syndrome	0.000192	0.000219	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling by GPCR—IL6—polycystic ovary syndrome	0.000157	0.00018	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling by GPCR—IL6—polycystic ovary syndrome	0.000155	0.000177	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—VEGFA—polycystic ovary syndrome	0.000134	0.000153	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—VEGFA—polycystic ovary syndrome	0.000132	0.000151	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—IL6—polycystic ovary syndrome	9.28e-05	0.000106	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—IL6—polycystic ovary syndrome	9.13e-05	0.000104	CbGpPWpGaD
